insitro, which uses machine learning for drug discovery and development, raises $143M Series B led by Andreessen Horowitz, bringing total raised to $243M (Leah Rosenbaum/Forbes)
insitro, which uses machine learning for drug discovery and development, raises $143M Series B led by Andreessen Horowitz, bringing total raised to $243M (Leah Rosenbaum/Forbes) https://ift.tt/2ZEAoiE
insitro, which uses machine learning for drug discovery and development, raises $143M Series B led by Andreessen Horowitz, bringing total raised to $243M — When it comes to biotech company Insitro, it's not the machine learning platform or the cutting-edge biology that lures in investors: it's the founder and CEO, Daphne Koller.
0 Response to "insitro, which uses machine learning for drug discovery and development, raises $143M Series B led by Andreessen Horowitz, bringing total raised to $243M (Leah Rosenbaum/Forbes)"
Post a Comment
THANK YOU